S879 RESULTS OF ASTRAL-1 STUDY, A PHASE 3 RANDOMIZED TRIAL OF GUADECITABINE (G) VS TREATMENT CHOICE (TC) IN TREATMENT NAÏVE ACUTE MYELOID LEUKEMIA (TN-AML) NOT ELIGIBLE FOR INTENSIVE CHEMOTHERAPY (IC)

Autor: Patricia Kropf, X. Thomas, P. Fenaux, J. Brandwein, Y. H. Min, J. Krauter, J. Novak, H. Kantarjian, J. Mayer, G.J. Roboz, Mohammad Azab, Hartmut Döhner, Wiesław Wiktor Jędrzejczak, Judit Demeter, K. Döhner, Y. Miyazaki, L. Gercheva-Kyuchukova, M. Gobbi, J.-P. Issa, Elizabeth A. Griffiths, T. Robak, K. Yee, S.-P. Yeh, M. Ojeda-Uribe

Publikováno v: HemaSphere. 3:394-395

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d026fb2f0a71d77b431cc3eb04ad02e6
https://doi.org/10.1097/01.hs9.0000561796.30124.a4

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Combination of rituximab, bortezomib, doxorubicin, dexamethasone and chlorambucil (RiPAD+C) as first-line therapy for elderly mantle cell lymphoma patients: results of a phase II trial from the GOELAMS

Autor: A. El Yamani, Roch Houot, J L Harousseau, Kamal Bouabdallah, Stéphane Courby, M. Ojeda Uribe, Nina Arakelyan, M. Alexis Vigier, Hervé Maisonneuve, Philippe Rodon, Caroline Dartigeas, S. Le Gouill, Remy Gressin, O. Tournilhac, Marie-Pierre Moles, Laurent Sutton, Luc Mathieu Fornecker, D. Assouline, Sylvie Caulet-Maugendre, Christiane Mounier

Publikováno v: Annals of Oncology
Annals of Oncology, 2012, 23 (6), pp.1555-61. ⟨10.1093/annonc/mdr450⟩
Annals of Oncology, Elsevier, 2012, 23 (6), pp.1555-61. ⟨10.1093/annonc/mdr450⟩
Annals of Oncology, Oxford University Press (OUP), 2012, 23 (6), pp.1555-61. ⟨10.1093/annonc/mdr450⟩

International audience; BACKGROUND: There is no consensual first-line chemotherapy for elderly patients with mantle cell lymphoma (MCL). The GOELAMS (Groupe Ouest-Est des Leucémies Aiguës et Maladies du Sang) group previously developed the (R)VAD+C

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80680ac9758f397fa5d55a714413ee05
https://hal.science/hal-00744066

Les manifestations auto-immunes sont corrélées à l’expression de ZAP-70 par le clone malin au cours de la leucémie lymphoïde chronique

Autor: Anne-Marie Knapp, Thierry Martin, Raoul Herbrecht, Bernard Drenou, M. Ojeda-Uribe, V. Rimelen, Y. Arkam, J.C. Eisenmann, D. Ghergus

Publikováno v: La Revue de Médecine Interne. 35:A179

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::634ffa740e2758073d12c86ec719c735
https://doi.org/10.1016/j.revmed.2014.03.302

P-087 SAA associated to a del(5)(q15q31) clone not involving EGR1: Progression of this clone contrasting with SAA improvement under immunosuppressive therapy

Autor: M. Ojeda-Uribe, M. Moldovan, J. Passweg, A. Renneville, S. Thiebault, Laurent Mauvieux, A. Debliquis, C. Gervais, Antoine Ittel, Eric Jeandidier

Publikováno v: Leukemia Research. 37:S61

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c30dd54976573a5fe2991b764d651882
https://doi.org/10.1016/s0145-2126(13)70136-x